Omics | Technique | Application | Limitation |
---|---|---|---|
Genome | SNS [105] | Detect DNA mutations including CNVs, SVs, SNVs in cancer cells, contributing to knowing dynamics of tumorigenesis, heterogeneous of tumors and identifying specific cancer clones | Low throughput |
SCI-seq [106] | Currently limited to CNV detection | ||
SCANPY [107] | Python-based rather than R-based frameworks | ||
SMOOTH-seq [108] | Low throughput | ||
Epigenome | scATAC-seq [109] | Detect the open status of chromatins; Link regulatory elements to their target genes and discover in vivo correlates of heterogeneity in accessibility within cell types; Explain heterogeneity in the shift of cell states and epigenetic mechanisms for CAR-T exhaustion, differentiation and resistance | Remain challenges in detection of large-scale SVs and haplotype phasing Speculate TF binding from motif or chromatin profiling data indirectly |
sciATAC-seq [110] | Speculate TF binding from motif or chromatin profiling data indirectly | ||
scNanoATAC-seq [111] | Expensive under current sequencing depth (less than 2.5 dollars per cell) Speculate TF binding from motif or chromatin profiling data indirectly | ||
scTHS-seq [126] | Improve coverage of highly cell specific distal enhancers compared with scATAC-seq | High cost | |
scDrop-CHIP [112] | Learn heterogeneity of tumors from aspects of histone modification and transfer factor binding directly, offer the opportunity to predict sensitivity to therapeutic agents [127] | Non-duplicated reads are low (less than 1000) | |
High cost | |||
Spatial-CUT&Tag [115] | High cost | ||
scBS-seq [116] | Detect DNA methylation to study cell development and connections between methylation and diseases | Very low cell throughput | |
scCGI-seq [117] | |||
snmC-seq [128] snmC-seq2 [129] | High cost | ||
sci-MET [130] | The coverage of methylation is not enough | ||
scRRBS [131] | Very low cell throughput Not full-length genome | ||
scHi-C-seq [83] | Specific for chromosome conformation | Very low cell throughput | |
Transcriptome | SMART-seq SMART-seq2 [132] SMART-seq3 [133] | Suitable for samples with small numbers of cells; Find rare fragments in mRNA by its whole mRNA sequencing | Low throughput Long experimental period |
CEL-seq [134] CEL-seq2 [135] | Identify cell types, discover tumor cells and TME, explain treatment outcomes and mechanism of diseases from clonal dynamics and other transcriptional profiles; MARS-seq2.0 enables intuitive approaches for depletion or enrichment of cell populations | Low throughput 3′-end counting, not full-length | |
3′-end counting, not full-length | |||
Drop-seq [102] | |||
InDrop [138] | |||
Seq-Well [139] | |||
MULTI-seq [140] | |||
It’s cost-efficient, allowing for the mapping of cell atlas [141, 142] | Not full-length | ||
Beside applications above, they can acquire sequencing of TCR & BCR beside gene transcripts as well, which are helpful for immune cell phenotype and associated cancers | High cost | ||
BD Rhapsody [145] | |||
SPLiT-seq [146] | It allows super high-throughput sequencing, and support to draw comprehensive atlas of cells or find rare cell clusters | 3′-end counting, not full-length | |
sci-RNA-seq [147] sci-RNA-seq3 [148] | Limited to detect exon High cost | ||
sci-Plex [149] | sci-Plex scales to thousands of samples, enables high-throughput sequencing and multiplex chemical transcriptomics at single-cell level. It’s a cost-effective and scalable method, allowing large-scale drug screening | Only affix barcodes to nuclei of cells, which means detecting mRNA in nuclei alone | |
scISOr-seq [150] | Using the third-generation sequencing platform to get full-length transcripts | High cost Low throughput High error rate | |
ScNaUmi-seq [151] | |||
R2C2 [152] | |||
Proteome | High-resolution microscopy [153] | Quantify proteins in single cells; Biomarker detection | The number of screened proteins is small High false positive rate |
Flow cytometry [154] | |||
Immunohistochemistry [155] | |||
CyTOF [156] | Quantify multiple proteins in single cells; Immune profiling; Biomarker discovery | Limited in the number of parameters cells per sample they can simultaneously assess High cost | |
BD Abseq [157] BioLegend TotalSeq [158] | High cost | ||
Single-cell sequencing is performed simultaneously at the transcriptome and proteome levels |